Amarantus Provides Update on Capital Restructuring and Announces Participation in RESI JPM 2018
09 janv. 2018 10h59 HE
|
Amarantus Bioscience Holdings, Inc.
Convertible securities holders grant 45-day extension to complete Tender Exchange Elto Pharma recruiting seasoned management to lead "Go-Public" transaction Management...